| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 05/22/2002 | CN1350523A Indoline derivatives as progesterohe antagonists |
| 05/22/2002 | CN1349987A Soybean isoflavone and its prepn process with macroporous adsorption resin |
| 05/22/2002 | CN1085207C Photochromic naphtho (2,1-B)pyrans |
| 05/21/2002 | US6392043 Photochromism compounds |
| 05/21/2002 | US6392010 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391907 Anticancer agents; contraceptives |
| 05/21/2002 | US6391616 Oidiodendron strain for the production of terpenoid lactone compounds |
| 05/21/2002 | US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide |
| 05/21/2002 | US6391310 Composition made from plant matter enriched in at least two phytochemicals selected from isoflavones, lignans, saponins, catechins and phenolic acids; treatment for neurological or immunological symptoms, inflammation, migraines and dementia |
| 05/21/2002 | US6391309 Composition made from plant matter enriched in at least two phytochemicals selected from isoflavones, lignans, saponins, sapogenins, catechins and phenolic acids; therapeutic treatment for female disorders |
| 05/21/2002 | US6391308 Method of preparing and using isoflavones for the treatment of blood related illnesses |
| 05/21/2002 | CA2061699C Pyranyl cyanoguanidine derivatives |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001045663A3 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1204714A1 Bi-or terthienyl substituted photochromic naphtho 2,1-b]pyran compounds |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/14/2002 | US6388123 Substituted phenyl keto enols as pesticides and herbicides |
| 05/14/2002 | US6387899 Antiserotonine agents; antidepressants |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387882 Vision defects; oxidation resistance; cosmetics; water solubility |
| 05/14/2002 | US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time |
| 05/14/2002 | US6387512 For coloring inks, fuels, plastics or glass |
| 05/14/2002 | CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes |
| 05/14/2002 | CA2010542C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 05/10/2002 | WO2002036832A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | WO2001076570A3 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses |
| 05/10/2002 | WO2001003681A3 Use of flavones, coumarins and related compounds to treat infections |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/09/2002 | US20020055644 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
| 05/09/2002 | US20020055537 Treating a crop infected with a phytopathogenic animal pest; treatment of vertebrates and humans infested by helminths or ectoparasites. |
| 05/09/2002 | US20020055471 Purification step using a brominated polystyrene resin to adsorb anthocyanins |
| 05/09/2002 | US20020055045 Novel materials useful as electrolytic solutes |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
| 05/08/2002 | EP1202736A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP1119554A4 Xanthan-ester and acridan substrates for horseradish peroxidase |
| 05/08/2002 | EP1043322B1 Vitamin e derivatives |
| 05/08/2002 | DE10054932A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections |
| 05/08/2002 | CN1348448A Methods for separating a tocopherol from a tocopherol-containing mixture and compositions thereof |
| 05/08/2002 | CN1348368A ADP-ribosylation inhibitors and remedies for endotoxin bacterial enteric infection containing proanthocyanidin as the active ingredient |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384245 Method for preparing DL-α-tocopherol with high yield |
| 05/07/2002 | US6384244 Hydrogenating oxime in presence of a catalyst and an acid; useful as chemical intermediates in production of hiv protease inhibitors |
| 05/07/2002 | US6384225 Intermediates in the preparation of substituted chroman derivatives |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6383392 Using nanofiltration membrane |
| 05/02/2002 | WO2002034738A1 Method for preparing dl-alpha-tocopherol with high yield |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052499 Photochromic naphthopyrans |
| 05/02/2002 | US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors. |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1201227A2 Use of flavonoids as immunomodulating or immunoprotecting agents in cosmetic and dermatological compositions |
| 05/02/2002 | EP1200421A1 Process for producing isocoumarins and intermediates for the same |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/01/2002 | CN1347406A Carbamic acid derivs. and their use as metabotropic glutamate receptor ligands |
| 04/30/2002 | US6380431 Quaternary ammonium compound |
| 04/30/2002 | US6380429 Oxidation of sulfonamide |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient |
| 04/25/2002 | WO2002032891A1 Flavan compounds, their preparation and their use in therapy |
| 04/25/2002 | WO2002032420A1 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 04/25/2002 | WO2001092563A3 Method for detecting a detectable product |
| 04/25/2002 | WO2001092250A3 Synthesis of 2-acyl substituted chromanes and intermediates thereof |
| 04/25/2002 | US20020049341 Photochromic spiropyrans, and compositions and articles containing same |
| 04/25/2002 | US20020049340 In presence of palladium catalyst without oxygen activation |
| 04/25/2002 | US20020049250 PPAR receptor activator compounds for treating cutaneous disorders/afflictions |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 04/25/2002 | US20020049166 Antineoplastic agents and antioxidants; preservative and topiosomerase-inhibiting compositions |
| 04/25/2002 | US20020048797 Fungicidal mixture; for killing plant parasites |
| 04/25/2002 | US20020048555 Artificial tanning compositions comprising flavylium salts |
| 04/25/2002 | US20020048540 Method to improve the selectivity of liquid-phase chemical reactions and the reactor system for this method |
| 04/25/2002 | DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | CA2424356A1 Supercritical co2 extraction of tetrahydrocannabinol and cannabidiol from cannabis plant material |
| 04/24/2002 | EP1199304A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
| 04/24/2002 | EP1199076A2 Medicament containing tocotrienol as active component |
| 04/24/2002 | EP1199071A2 Use of an estrogen agonist/antagonist for improving vascular health |
| 04/24/2002 | EP0822813B1 A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a antagonist |
| 04/24/2002 | CN1083449C Nonionic vitamin E derivatives and method for prparation thereof, and polymeric amphiphilic vesicles made therefrom |
| 04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
| 04/23/2002 | CA2256478C Novel photochromic indeno-fused naphthopyrans |
| 04/23/2002 | CA2229504C Flavanone-containing composition |
| 04/18/2002 | WO2002030916A1 Naphthopyrans annelated in c5-c6 with a dihydrobenzocycloheptatriene-type carbocycle, and compositions and matrices containing them |
| 04/18/2002 | WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030438A1 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 04/18/2002 | WO2002030407A1 ESTROGEN RECEPTOR-β LIGANDS |
| 04/18/2002 | WO2002010432A3 Triphosphate oligonucleotide modification reagents and uses thereof |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001070719A3 Hydroxylated/carboxylated naphthopyrans |